查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1492429

溴替唑仑市场：按类型、应用和分布 - 2024-2030 年全球预测

Brotizolam Market by Type (Capsule, Tablet), Application (Anxiety Treatment, Insomnia Treatment), Distribution - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年溴替唑仑市场规模为3.2972亿美元，预计2024年将达3.500亿美元，2030年将达5.1105亿美元，复合年增长率为6.46%。

布替唑仑是一种苯二氮平衍生物，具有强效催眠作用，主要用于短期治疗失眠。它增强大脑中神经传导物质的活性，产生镇静作用，促进睡眠的启动和维持。世界各地患有睡眠障碍，特别是失眠的人数正在增加，这增加了对布替唑仑的需求。老年人更容易出现睡眠障碍。世界老年人口的增加增加了对安眠药（包括布替唑仑）的需求，以有效管理睡眠障碍。然而，复杂性和实现最佳品质的配方困难阻碍了该药物的普及。潜在的副作用和难以给予适当剂量，再加上溴替唑仑的其他性能问题，阻碍了患者对该药物的偏好。持续的研究和开发工作专注于提高安眠药的功效和安全性，这将使溴替唑仑被纳入新的、更有效的治疗方法中，前景乐观。将溴替唑仑与其他治疗方法（药物和非药物）结合使用可提供治疗失眠的综合方法，并可能改善患者的预后。

主要市场统计
基准年[2023] 3.2972亿美元
预测年份 [2024] 3.5亿美元
预测年份 [2030] 51105万美元
复合年增长率（%） 6.46%

区域洞察

美洲，特别是美国和加拿大，由于其强大的医疗基础设施、广泛的保险政策以及大型製药公司的存在，为溴替唑仑市场扩张提供了巨大的机会。亚太地区的药物开发和研究格局正在兴起，这显示了布替唑仑市场的发展潜力。研究和投资工作越来越集中于开发符合当地市场预期的药品，包括助眠剂。布替唑仑作为亚太地区药品製造中心的战略地位促进了布替唑仑的成长。在欧盟，溴替唑仑市场的特点是严格的监管要求，重点在于消费者安全和产品功效。人口迅速老化正在增加对含有溴替唑仑的睡眠辅助剂的需求。在中东和非洲，市场动态和消费行为高度依赖特定国家的法规环境、经济状况以及对心理健康和药物干预的文化态度。其中一些地区正在增加对医疗保健基础设施和服务的投资，如果获得监管部门的核准，这可能会为溴替唑仑等药物开闢新的途径。

FPNV定位矩阵

FPNV 定位矩阵对于评估溴替唑仑市场供应商的定位至关重要。此矩阵提供了对供应商的全面评估，并检验了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果，供应商被分为代表其成功程度的四个像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对溴替唑仑市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献，您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外，该分析还提供了对该行业竞争性质的宝贵见解，包括在研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息，供应商可以做出更明智的决策并製定有效的策略，以在市场竞争中保持领先地位。

策略分析与建议

策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对布替唑仑市场当前地位的全面评估使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析，以确定核心优势和需要改进的领域。

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 渗出性疾病增加和人口快速老化
      • 提高对精神疾病相关症状的认识
    • 抑制因素
      • 配方复杂且需要品管
    • 机会
      • 不断创新研发努力，提升布替唑仑的性能与功效
      • 政府和监管机构核准布替唑仑
    • 任务
      • 与使用溴替唑仑相关的表现问题
  • 市场区隔分析
    • 类型：溴替唑仑片剂因其成本效益、稳定性和易于剂量控製而越来越受到青睐。
    • 用途：利用起效快、催眠效果显着的溴替唑仑治疗失眠
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章 溴替唑仑市场：依类型

  • 胶囊
  • 药片

第七章 溴替唑仑市场：依应用分类

  • 焦虑症治疗
  • 治疗失眠

第八章 溴替唑仑市场经销商

  • 医院药房
  • 网路药房
  • 零售药房

第九章 美洲布替唑仑市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章 亚太地区溴替唑仑市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲溴替唑仑市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • SUSMED 创新失眠治疗应用程式获得核准
    • 扩大 QUVIVIQ® 的使用范围：策略性纳入 CVS 保险范围将促进失眠治疗的普及
  • 战略分析和建议

第13章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-6B0EA079758A

[183 Pages Report] The Brotizolam Market size was estimated at USD 329.72 million in 2023 and expected to reach USD 350.00 million in 2024, at a CAGR 6.46% to reach USD 511.05 million by 2030.

Brotizolam is a benzodiazepine derivative with potent hypnotic properties, making it primarily used in the short-term management of insomnia. It functions by enhancing the action of neurotransmitters in the brain to produce a calming effect, thereby facilitating the onset and maintenance of sleep. The increasing number of individuals suffering from sleep disorders, particularly insomnia, across the globe has accentuated the need for brotizolam. Older adults are more prone to sleep disturbances. The global increase in the elderly population has led to a higher need for hypnotic medications, including brotizolam, to manage sleep disorders effectively. However, complexities in achieving optimum quality and formulation difficulties can hamper the widespread adoption of the medicine. Potential side effects and difficulties in delivering the right dosage, coupled with other performance issues of brotizolam, hinder patient preference for the drug. Continuous research and development activities focusing on improving the efficacy and safety profile of hypnotic drugs provide a positive outlook for brotizolam, incorporating it into newer, more effective treatment regimens. There's an opportunity to explore and develop combination therapies where brotizolam is used alongside other treatments, both pharmacological and non-pharmacological, to provide a comprehensive approach to managing insomnia with potentially enhanced patient outcomes.

KEY MARKET STATISTICS
Base Year [2023] USD 329.72 million
Estimated Year [2024] USD 350.00 million
Forecast Year [2030] USD 511.05 million
CAGR (%) 6.46%

Regional Insights

In the Americas region, particularly in the U.S. and Canada, there is considerable opportunity for expanding the brotizolam market, driven by the presence of a robust healthcare infrastructure, expansive insurance policies, and key pharmaceutical companies. APAC's drug development and research landscape is emerging, signifying the potential for progress in the brotizolam market. Research and investment efforts are progressively emphasizing the development of pharmaceuticals, including sleeping aids, that harmonize with local market expectations. APAC's strategic position as a pharmaceutical manufacturing hub has enabled the growth of brotizolam medication. In the EU, the market for brotizolam is characterized by stringent regulatory requirements focusing on consumer safety and product efficacy. The presence of a rapidly aging population accentuates the need for sleeping aids, including brotizolam. In the Middle East and Africa, the market dynamics and consumer behavior vastly depend on the specific country's regulatory environment, economic conditions, and cultural attitudes toward mental health and pharmaceutical interventions. Some regions within these areas are seeing increased investments in healthcare infrastructure and services, potentially opening up new avenues for medications such as brotizolam, subject to regulatory approvals.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Brotizolam Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Increasing prevalence of seeping disorders and a rapidly aging population
      • Growing awareness about symptoms related to mental health disorders
    • Market Restraints
      • Formulation complexities and need for high quality control
    • Market Opportunities
      • Ongoing innovations and R&D initiatives to improve the performance and efficacy of brotizolam
      • Supportive government and regulatory approvals for brotizolam
    • Market Challenges
      • Performance issues associated with the use of brotizolam
  • Market Segmentation Analysis
    • Type: Emerging preference for tablets of brotizolam owing to their cost-effectiveness, stability, and ease of controlling dosage
    • Application: Insomnia treatment benefiting from the rapid onset and pronounced hypnotic effect of brotizolam
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Brotizolam Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Brotizolam Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

SUSMED, Inc. Secures Approval for Innovative Insomnia Treatment App

SUSMED, Inc. has received approval from the Ministry of Health, Labour and Welfare (MHLW) for its SUSMED Med CBT-i App, an insomnia treatment application. The smartphone-based app is designed to offer cognitive behavioral therapy for insomnia (CBT-I) over a course of nine weeks, showing significant therapeutic benefits for individuals suffering from insomnia. By adhering to the app's guidance, users can see an improvement in their symptoms, while physicians can track their progress through an integrated management system. This approval marks a pivotal step towards the application's market launch, with SUSMED currently working towards securing insurance coverage for the product. [Published On: 2023-08-25]

Expanding Access to QUVIVIQ(R): Strategic Inclusion in CVS Coverage Enhances Insomnia Therapy Reach

Idorsia Ltd and its U.S. subsidiary have announced a significant development, that CVS would include QUVIVIQ (daridorexant) CIV in its Performance Drug List (PDL), effective immediately. This inclusion marks a pivotal moment, as it significantly broadens access to QUVIVIQ, a modern prescription insomnia treatment, by encompassing an audience of around 20 million people enrolled under CVS's plan. With this move, QUVIVIQ secures coverage by two of the United States' major insurance providers, Express Scripts and CVS, in addition to various regional plans and TRICARE, the dedicated healthcare program for U.S. military members, veterans, and their families. [Published On: 2023-07-10]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Brotizolam Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Brotizolam Market, highlighting leading vendors and their innovative profiles. These include Amneal Pharmaceuticals LLC, Aurobindo Pharma Limited, Boehringer Ingelheim International GmbH., Choseido Pharmaceutical Co., Ltd., Daiko Pharmaceutical Co.,Ltd., Delphis Pharmaceutical, Kyowa Pharmaceutical Industry Co.,Ltd., Medilux Laboratories Pvt. Ltd., Merck KGaA, Mylan N.V., Nichi-Iko Pharmaceutical Co.,Ltd., Nipro Corp., Nissin Pharmaceutical Co.,Ltd., Ohara Pharmaceutical Co.,Ltd., Sannova Analytical LLC, Tatsumi Kagaku Co.,Ltd., Teva Takeda Pharma Ltd., and Yoshindo Inc..

Market Segmentation & Coverage

This research report categorizes the Brotizolam Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Capsule
    • Tablet
  • Application
    • Anxiety Treatment
    • Insomnia Treatment
  • Distribution
    • Hospital Pharmacies
    • Online Pharmacies
    • Retail Pharmacies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of seeping disorders and a rapidly aging population
      • 5.1.1.2. Growing awareness about symptoms related to mental health disorders
    • 5.1.2. Restraints
      • 5.1.2.1. Formulation complexities and need for high quality control
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing innovations and R&D initiatives to improve the performance and efficacy of brotizolam
      • 5.1.3.2. Supportive government and regulatory approvals for brotizolam
    • 5.1.4. Challenges
      • 5.1.4.1. Performance issues associated with the use of brotizolam
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Emerging preference for tablets of brotizolam owing to their cost-effectiveness, stability, and ease of controlling dosage
    • 5.2.2. Application: Insomnia treatment benefiting from the rapid onset and pronounced hypnotic effect of brotizolam
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Brotizolam Market, by Type

  • 6.1. Introduction
  • 6.2. Capsule
  • 6.3. Tablet

7. Brotizolam Market, by Application

  • 7.1. Introduction
  • 7.2. Anxiety Treatment
  • 7.3. Insomnia Treatment

8. Brotizolam Market, by Distribution

  • 8.1. Introduction
  • 8.2. Hospital Pharmacies
  • 8.3. Online Pharmacies
  • 8.4. Retail Pharmacies

9. Americas Brotizolam Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Brotizolam Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Brotizolam Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. SUSMED, Inc. Secures Approval for Innovative Insomnia Treatment App
    • 12.3.2. Expanding Access to QUVIVIQ(R): Strategic Inclusion in CVS Coverage Enhances Insomnia Therapy Reach
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. BROTIZOLAM MARKET RESEARCH PROCESS
  • FIGURE 2. BROTIZOLAM MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BROTIZOLAM MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BROTIZOLAM MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL BROTIZOLAM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. BROTIZOLAM MARKET DYNAMICS
  • FIGURE 7. GLOBAL BROTIZOLAM MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL BROTIZOLAM MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL BROTIZOLAM MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL BROTIZOLAM MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS BROTIZOLAM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS BROTIZOLAM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES BROTIZOLAM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES BROTIZOLAM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC BROTIZOLAM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC BROTIZOLAM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BROTIZOLAM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BROTIZOLAM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. BROTIZOLAM MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. BROTIZOLAM MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BROTIZOLAM MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BROTIZOLAM MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL BROTIZOLAM MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL BROTIZOLAM MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL BROTIZOLAM MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL BROTIZOLAM MARKET SIZE, BY CAPSULE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL BROTIZOLAM MARKET SIZE, BY CAPSULE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL BROTIZOLAM MARKET SIZE, BY TABLET, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL BROTIZOLAM MARKET SIZE, BY TABLET, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL BROTIZOLAM MARKET SIZE, BY ANXIETY TREATMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL BROTIZOLAM MARKET SIZE, BY ANXIETY TREATMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL BROTIZOLAM MARKET SIZE, BY INSOMNIA TREATMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL BROTIZOLAM MARKET SIZE, BY INSOMNIA TREATMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL BROTIZOLAM MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL BROTIZOLAM MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL BROTIZOLAM MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL BROTIZOLAM MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL BROTIZOLAM MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL BROTIZOLAM MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. AMERICAS BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 28. AMERICAS BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 29. AMERICAS BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 30. AMERICAS BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 31. AMERICAS BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 32. AMERICAS BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 33. AMERICAS BROTIZOLAM MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 34. AMERICAS BROTIZOLAM MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 35. ARGENTINA BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 36. ARGENTINA BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 37. ARGENTINA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 38. ARGENTINA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 39. ARGENTINA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 40. ARGENTINA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 41. BRAZIL BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 42. BRAZIL BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 43. BRAZIL BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 44. BRAZIL BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 45. BRAZIL BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 46. BRAZIL BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 47. CANADA BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 48. CANADA BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 49. CANADA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 50. CANADA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 51. CANADA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 52. CANADA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 53. MEXICO BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 54. MEXICO BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 55. MEXICO BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 56. MEXICO BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 57. MEXICO BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 58. MEXICO BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 59. UNITED STATES BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 60. UNITED STATES BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 61. UNITED STATES BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 62. UNITED STATES BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 63. UNITED STATES BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 64. UNITED STATES BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 65. UNITED STATES BROTIZOLAM MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 66. UNITED STATES BROTIZOLAM MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC BROTIZOLAM MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC BROTIZOLAM MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 76. AUSTRALIA BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 78. AUSTRALIA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 80. AUSTRALIA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 81. CHINA BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 82. CHINA BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 83. CHINA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 84. CHINA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 85. CHINA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 86. CHINA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 87. INDIA BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 88. INDIA BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 89. INDIA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 90. INDIA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 91. INDIA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 92. INDIA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 93. INDONESIA BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 94. INDONESIA BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 95. INDONESIA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 96. INDONESIA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 97. INDONESIA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 98. INDONESIA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 99. JAPAN BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 100. JAPAN BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 101. JAPAN BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 102. JAPAN BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 103. JAPAN BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 104. JAPAN BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 105. MALAYSIA BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 106. MALAYSIA BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 107. MALAYSIA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 108. MALAYSIA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 109. MALAYSIA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 110. MALAYSIA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 112. PHILIPPINES BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 114. PHILIPPINES BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 116. PHILIPPINES BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 117. SINGAPORE BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 118. SINGAPORE BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 119. SINGAPORE BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 120. SINGAPORE BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 121. SINGAPORE BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 122. SINGAPORE BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 124. SOUTH KOREA BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 126. SOUTH KOREA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 128. SOUTH KOREA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 129. TAIWAN BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 130. TAIWAN BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 131. TAIWAN BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 132. TAIWAN BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 133. TAIWAN BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 134. TAIWAN BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 135. THAILAND BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 136. THAILAND BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 137. THAILAND BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 138. THAILAND BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 139. THAILAND BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 140. THAILAND BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 141. VIETNAM BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 142. VIETNAM BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 143. VIETNAM BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 144. VIETNAM BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 145. VIETNAM BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 146. VIETNAM BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA BROTIZOLAM MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA BROTIZOLAM MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 155. DENMARK BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 156. DENMARK BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 157. DENMARK BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 158. DENMARK BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 159. DENMARK BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 160. DENMARK BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 161. EGYPT BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 162. EGYPT BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 163. EGYPT BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 164. EGYPT BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 165. EGYPT BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 166. EGYPT BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 167. FINLAND BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 168. FINLAND BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 169. FINLAND BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 170. FINLAND BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 171. FINLAND BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 172. FINLAND BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 173. FRANCE BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 174. FRANCE BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 175. FRANCE BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 176. FRANCE BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 177. FRANCE BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 178. FRANCE BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 179. GERMANY BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 180. GERMANY BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 181. GERMANY BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 182. GERMANY BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 183. GERMANY BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 184. GERMANY BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 185. ISRAEL BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 186. ISRAEL BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 187. ISRAEL BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 188. ISRAEL BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 189. ISRAEL BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 190. ISRAEL BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 191. ITALY BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 192. ITALY BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 193. ITALY BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 194. ITALY BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 195. ITALY BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 196. ITALY BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 198. NETHERLANDS BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 200. NETHERLANDS BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 202. NETHERLANDS BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 203. NIGERIA BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 204. NIGERIA BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 205. NIGERIA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 206. NIGERIA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 207. NIGERIA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 208. NIGERIA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 209. NORWAY BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 210. NORWAY BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 211. NORWAY BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 212. NORWAY BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 213. NORWAY BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 214. NORWAY BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 215. POLAND BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 216. POLAND BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 217. POLAND BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 218. POLAND BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 219. POLAND BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 220. POLAND BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 221. QATAR BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 222. QATAR BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 223. QATAR BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 224. QATAR BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 225. QATAR BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 226. QATAR BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 227. RUSSIA BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 228. RUSSIA BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 229. RUSSIA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 230. RUSSIA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 231. RUSSIA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 232. RUSSIA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 234. SAUDI ARABIA BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 236. SAUDI ARABIA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 238. SAUDI ARABIA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 240. SOUTH AFRICA BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 242. SOUTH AFRICA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 244. SOUTH AFRICA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 245. SPAIN BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 246. SPAIN BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 247. SPAIN BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 248. SPAIN BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 249. SPAIN BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 250. SPAIN BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 251. SWEDEN BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 252. SWEDEN BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 253. SWEDEN BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 254. SWEDEN BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 255. SWEDEN BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 256. SWEDEN BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 258. SWITZERLAND BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 260. SWITZERLAND BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 262. SWITZERLAND BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 263. TURKEY BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 264. TURKEY BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 265. TURKEY BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 266. TURKEY BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 267. TURKEY BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 268. TURKEY BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 276. UNITED KINGDOM BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 278. UNITED KINGDOM BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 280. UNITED KINGDOM BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 281. BROTIZOLAM MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 282. BROTIZOLAM MARKET, FPNV POSITIONING MATRIX, 2023